第二代机器人血管成形术系统用于治疗ST段抬高型心肌梗死：首例人体概念验证病例报告。

Second-generation robotic angioplasty system use for the treatment of ST-elevation myocardial infarction: a first-in-man proof of concept case report.

作者信息

Hofmann Felix J, Dörr Oliver, Blachutzik Florian, Elsässer Albrecht, Möllmann Helge, Köhne Alessa-Janine, Nef Holger M

机构信息

Department of Cardiology and Angiology, University Hospital of Giessen and Marburg, Klinikstraße 33, 35392 Giessen, Germany.

Department of Cardiology, Klinikum Oldenburg, Rahel- Straus-Straße 10 26133 Oldenburg, Germany.

出版信息

Eur Heart J Case Rep. 2023 Mar 4;7(3):ytad089. doi: 10.1093/ehjcr/ytad089. eCollection 2023 Mar.

BACKGROUND

Robotically assisted remote-controlled PCI (rPCI) was introduced in the past decade as one of the latest enhancements in this rapidly evolving field. The use of a second-generation rPCI system in ST-elevation myocardial infarction (STEMI) is an effort to couple immediate revascularization with the accuracy of newer robotic assistance and software support.

CASE SUMMARY

Here we report on the safety and efficacy of rPCI applied to a 74-year-old female STEMI patient with persistent acute chest pain as well as regional wall motion abnormalities in the echocardiogram. The first medical contact-to-device time was 76 min, and door-to-balloon time was 33 min. The impatient course was uneventful, so the patient was discharged from hospital after 5 days. To the best of our knowledge, this is the first report of the successful application of second-generation rPCI in STEMI.

DISCUSSION

In the case presented, rPCI was feasible and safe even in acute coronary syndrome based on a single-centre experience. rPCI is a revolutionary new technique that may be applied to various types of clinical presentations.